Ana Fuentes
- Microbiology top 5%
- Reproductive tract infections research 5
- Hepatology top 5%
- Hepatitis C virus research 10
- Hepatitis Viruses Studies and Epidemiology 7
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 9
- SARS-CoV-2 detection and testing 6
- Viral gastroenteritis research and epidemiology 5
-
- Hepatitis B Virus Studies 7
- Co-authors
- Féderico GarcíaAdolfo de SalazarAntonio Barrientos‐DuránJulio Plaza‐DíazJuan A. PinedaAntonio Rivero‐JuárezAntonio RiveroMario Frías
- Journals
- PLoS ONE (1 paper)International Journal of Molecular Sciences (1 paper)Journal of Clinical Microbiology (1 paper)
- Partner nations
- SpainUnited StatesMexico
In The Last Decade
Ana Fuentes
33 papers receiving 468 citations
Peers
Comparison fields: 5 of 72
- Microbiology 139
- Hepatology 178
- Infectious Diseases 176
- Epidemiology 191
- Obstetrics and Gynecology 22
Countries citing papers authored by Ana Fuentes
This map shows the geographic impact of Ana Fuentes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Fuentes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Fuentes more than expected).
Fields of papers citing papers by Ana Fuentes
This network shows the impact of papers produced by Ana Fuentes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Fuentes. The network helps show where Ana Fuentes may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ana Fuentes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 9 | |
| 11 | 2022 | 81 | |
| 12 | 2022 | 22 | |
| 13 | 2021 | 2 | |
| 14 | 2021 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2021 | 7 | |
| 17 | 2021 | 3 | |
| 18 | 2020 | 17 | |
| 19 | 2020 | 19 | |
| 20 | 2019 | 22 |
About Ana Fuentes
Ana Fuentes is a scholar working on Hepatology, Infectious Diseases and Microbiology, having authored 37 papers that have together received 480 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (10 papers), Hepatitis C virus research (10 papers), COVID-19 Clinical Research Studies (9 papers), Hepatitis Viruses Studies and Epidemiology (7 papers), Hepatitis B Virus Studies (7 papers), SARS-CoV-2 detection and testing (6 papers), Viral gastroenteritis research and epidemiology (5 papers) and Reproductive tract infections research (5 papers). The work is most often cited by research in Microbiology (139 citations), Hepatology (178 citations) and Infectious Diseases (176 citations). Ana Fuentes has collaborated with scholars based in Spain, United States and Mexico. Frequent co-authors include Féderico García, Adolfo de Salazar, Antonio Barrientos‐Durán, Julio Plaza‐Díaz, Juan A. Pineda, Antonio Rivero‐Juárez, Antonio Rivero, Mario Frías, Ana Belén Pérez and Gabriel Reina. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.